SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN Limited is experiencing intense market volatility after pairing a significant strategic partnership and infrastructure expansion deal with NVIDIA alongside a report of weaker-than-expected quarterly results. While the community remains deeply divided, investors are actively debating whether the aggressive pivot to AI compute and long-term capacity guidance justifies the current valuation, or if the stock is being artificially bolstered by headline-driven sentiment.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending as investors weigh a record-shattering revenue backlog of nearly $100 billion against concerns over aggressive capital expenditure and debt-fueled growth. While the community remains deeply divided between long-term bulls betting on dominant AI infrastructure demand and skeptical bears pointing to recent margin compression, the stock's volatility is being exacerbated by heavy institutional hedging and uncertainty surrounding post-earnings price swings.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is facing extreme investor anxiety and bearish sentiment heading into its earnings release, with shareholders pointing to a consistent pattern of post-earnings sell-offs and a lack of executive transparency. While some investors are betting on a short squeeze or a potential OpenAI partnership, many are actively calling for leadership changes following significant executive turnover and a prolonged period of share price underperformance.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the community debates a strategic legal maneuver to rescind their U.S. distribution agreement with NS Pharma, a move seen by many as a calculated effort to clear the path for a potential buyout or a more effective commercial rollout. Investors are actively discussing the implications of this contract dispute on the timeline for Deramiocel ahead of its upcoming PDUFA date, with optimism centered on the possibility of a stronger, independent launch or a new partnership.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. It offers various products for performance and reliability, video streaming and delivery, advanced security, insights, Cloudflare for developers, domain registration, and Cloudflare marketplace. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflare is under significant pressure as the company implements a major AI-driven restructuring that includes a 20% workforce reduction, sparking market concerns regarding execution risks and the sustainability of its growth-at-all-costs model. While the company delivered a revenue beat and raised full-year guidance, the community remains divided, with some investors viewing the layoffs as necessary efficiency gains for an 'agentic' AI future, while others warn that the stock's premium valuation is increasingly difficult to justify amid slowing momentum.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is facing intense scrutiny from the investment community as shareholders demand clarity on revenue and contract execution ahead of its upcoming earnings report. The discourse is marked by skepticism over management's vague communication and a lack of tangible progress on major defense partnerships, leaving traders focused on whether the company can successfully scale production to meet its ambitious revenue targets.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending as investors weigh its potential as a distressed buyout candidate or short-squeeze play amid heavy short interest and significant underperformance. The community remains deeply divided, with some betting on a turnaround fueled by institutional ownership and international expansion, while others criticize persistent leadership uncertainty and declining consumer perception.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is experiencing extreme volatility following record first-quarter results, with the stock price dropping sharply as investors reacted to guidance that failed to meet high growth expectations despite overall performance beats. The community is deeply divided between those viewing the sell-off as an irrational overreaction to a solid business model and others warning of further downside due to concerns over valuation and intense competitive pressure.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is gaining attention following the release of its first-quarter 2026 financial results and an update on the pivotal Phase 3 registration path for CAD-1005 in patients with Heparin-Induced Thrombocytopenia. While some investors view the FDA-aligned regulatory progress as a key de-risking milestone, others in the community have expressed skepticism, citing frequent bot-driven spam and concerns over the company's long-term capital requirements.

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Atara Biotherapeutics Inc

Atara Biotherapeutics is facing significant market volatility following a second FDA rejection for its tabelecleucel therapy, with community debate centered on whether this reversal constitutes an unfair clinical trial assessment or an irreparable blow to the company's limited cash runway. Traders are actively discussing the risks of potential dilution and the company's future viability, while many remain focused on the potential for an expedited meeting to challenge the FDA's decision.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
